Pulsar Helium Raises £20,000 Through Exercise of 86,956 Warrants, Boosting Share Capital

Details of Warrant Exercise and Capital Inflow for Pulsar Helium

On 21 July 2026, Pulsar Helium Inc announced that 86,956 share purchase warrants were exercised on 20 July 2026. These warrants originated from the company’s offering that closed on 29 August 2025. The exercise price was set at £0.23 per share, a rate that incentivized warrant holders to fully exercise their rights at this stage. The transaction injected £19,999.88 into the company’s cash reserves, enhancing working capital for its helium production operations.

The timing of this exercise, nearly eleven months after the original offering, indicates sustained confidence from warrant holders in the company’s valuation and growth prospects. While warrant exercises dilute existing shareholders, they simultaneously strengthen Pulsar Helium’s financial position. The relatively modest cash inflow reflects the number of warrants exercised rather than any valuation concerns.

Admission to AIM and Impact on Share Capital Structure

Following the warrant exercise, Pulsar Helium has applied to the London Stock Exchange plc for admission of the 86,956 new common shares to trading on AIM. Admission and commencement of dealings are expected at 8:00 a.m. on or around 24 July 2026. Upon admission, these shares will rank equally with existing common shares, carrying identical rights and preferences.

This admission will increase the total number of common shares with voting rights to 214,197,181. This updated figure is critical for shareholders as it serves as the denominator for calculating notification obligations regarding interests in the company’s issued share capital under the company’s Articles. Shareholders with holdings near notification thresholds should reassess their positions accordingly. The expanded share base represents a significant change for those monitoring voting control and major shareholdings.

Multi-Exchange Listing and Market Presence of Pulsar Helium

Pulsar Helium Inc operates as a primary helium producer with listings on AIM (ticker: PLSR), TSX Venture Exchange (TSXV:PLSR), and OTCQB (ticker: PSRHF). This tri-exchange presence provides access to capital markets in the UK, Canada, and the US. Each listing imposes specific regulatory and reporting requirements, while the company’s core helium production business remains unified. The AIM listing is particularly relevant for UK and European investors seeking exposure to helium resource development.

The helium market has gained investor interest due to its critical applications in medical imaging, industrial cooling, scientific research, and semiconductor manufacturing. Pulsar Helium focuses on upstream helium production rather than downstream distribution. The company’s registered office is in Cascais, Portugal, although its production assets may be located elsewhere. The multi-exchange strategy reflects Pulsar Helium’s commitment to attracting a diverse investor base across multiple regions.

Shareholder Notification Requirements and Compliance

The company’s announcement highlights that shareholders must use the updated total of 214,197,181 common shares as the basis for calculating whether notification of interests or changes in interests in the company’s issued share capital is required. These thresholds, typically set at levels such as 5%, 10%, and 15%, are defined in the company’s Articles of Association to ensure transparency of significant holdings.

Shareholders approaching or exceeding these thresholds should review the company’s Articles to confirm their disclosure obligations. The updated voting rights figure is effective immediately with the expected admission date around 24 July 2026. Failure to comply with notification requirements can result in penalties including loss of voting rights. Strand Hanson Limited, the company’s Nominated Adviser, can provide further guidance on these obligations.

Overview of the Primary Helium Industry and Pulsar Helium’s Role

The primary helium sector involves extraction and production from natural gas reserves and helium-rich geological formations. Helium is vital for medical MRI cooling, semiconductor manufacturing, scientific research, and aerospace applications. As a primary helium company, Pulsar Helium focuses on exploration, development, and production of helium reserves, exposing it to commodity price fluctuations, regulatory risks, and geological challenges.

Recent supply constraints and increased demand have created opportunities for producers like Pulsar Helium. However, the company faces competition from established energy firms and helium specialists. The recent warrant exercise and capital raise underscore the company’s need for funding to advance its projects and operational goals.

Regulatory Environment on TSX Venture Exchange and Governance Structure

The announcement includes a standard TSX Venture Exchange disclaimer noting that the exchange and its Regulation Services Provider do not accept responsibility for the accuracy or adequacy of the release. As a dual-listed company on AIM and TSXV, Pulsar Helium complies with disclosure and governance requirements from both exchanges, enhancing investor confidence through multiple regulatory layers.

Led by CEO Thomas Abraham-James, the management team ensures regulatory compliance across listings. Strand Hanson Limited serves as Nominated Adviser and Financial Broker for AIM, while Yellow Jersey PR Limited manages investor communications. The company provides UK and North American contact details to facilitate investor relations and inquiries.

Financial Impact and Use of Proceeds from Warrant Exercise

The £19,999.88 cash proceeds from the warrant exercise represent a modest capital infusion that can support operational costs, exploration, or administrative expenses. While the announcement does not specify the use of funds, efficient capital management remains a priority for the developing helium producer. The exercise also signals warrant holders’ confidence in Pulsar Helium’s valuation at the £0.23 strike price.

This form of capital raising, triggered by warrant holders rather than a new equity offering, is less dilutive than a fresh share placement. Investors should consider the exercise alongside recent share price trends and company updates to assess its implications.

Risks Related to Helium Production and Share Dilution

Pulsar Helium faces risks typical of primary helium producers, including capital intensity, geographic concentration, regulatory approvals, and commodity price volatility. Helium reserves are finite, and production assets have limited lifespans. The warrant exercise dilutes existing shareholders by increasing total voting share capital. Future exercises or capital raises could cause additional dilution. The company has not disclosed the total outstanding warrants or options post-exercise, so potential further dilution remains uncertain.

Investor Engagement and Upcoming Trading Details

Investors can contact Pulsar Helium via email at [email protected] or by phone at +1 (218) 203-5301 (USA/Canada) and +44 (0) 2033 55 9889 (UK). Additional information is available on the company’s website https://pulsarhelium.com and LinkedIn page https://ca.linkedin.com/company/pulsar-helium-inc. This multi-channel approach supports active investor relations.

The newly issued shares are expected to begin trading on AIM at approximately 8:00 a.m. on 24 July 2026. While the volume of shares is small relative to total share capital, the listing provides liquidity for warrant holders. Investors should monitor trading activity and await further company announcements regarding operations, funding, or strategy. Strand Hanson Limited and Yellow Jersey PR Limited will coordinate investor communications related to the share admission.